Targeted purification development enabled by computational biophysical modeling

Francis K Insaidoo1, Michael A Rauscher, Shepard J Smithline

  • 1Merck Research Laboratories, Merck & Co., Inc, Whitehouse Station, NJ, 08889.

Biotechnology Progress
|December 9, 2014
PubMed
Summary

Computational models using atomic-level detail can predict and improve biopharmaceutical purification, specifically for insulin variants. This approach enhances understanding of protein-ligand interactions for more robust bioprocess development.

Related Concept Videos